SCHEMBL19988571

SCHEMBL19988571

Brc1ccc(Br)c2c1nc(-c1ccccc1)n2-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 1/20 0.47
▸ PI4K2B Q8TCG2 1/20 0.47
▸ PI4K2A Q9BTU6 1/20 0.47
▸ PI4KB Q9UBF8 1/20 0.47
▸ DHFR P00374 2/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ AVPR1A P37288 1/20 0.40
▸ HCAR1 Q9BXC0 1/20 0.40
▸ TSHR P16473 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.39
▸ HTT P42858 1/20 0.38
▸ CASR P41180 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18493217 0.82 PI4KA (0.54) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL16352519 0.82 ESR1 (0.48) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL29386178 0.82 ESR1 (0.48) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL22665831 0.80 PI4KA (0.37) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL25585790 0.79 ESR1 (0.48) PI4KAPI4K2BPI4K2API4KBESR1
SCHEMBL31349388 0.78 ADORA2B (0.46) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL21155155 0.77 ALDH1A1 (0.43) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL2631757 0.75 MEN1 (0.48) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL28979811 0.75 PI4KA (0.48) PI4KAPI4K2BPI4K2API4KBDHFR
SCHEMBL15796922 0.74 ALDH1A1 (0.44) PI4KAPI4K2BPI4K2API4KBDHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040491-A Silicon-containing organic compound and application thereof, composition, adhesive film, preparation method and application thereof, photovoltaic module and preparation method thereof 江苏绿人半导体有限公司 2025-05-27 — — CN disclosed
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 PI4KA 1984/4885PI4K2B 2740/4885PI4K2A 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback